Your trusted source for investing success

Tag: biotechnology

Revive Therapeutics Announces Update on its Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis…

Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid-based pharmaceutical markets, today announced an update on the Company’s collaboration agreement with Chemi Pharmaceutical Inc. (“Chemi Pharma”), a Licensed Dealer for

Valens GroWorks Announces $5,000,000 Funding

Valens GroWorks Announces $5,000,000 Funding

Valens GroWorks Corp. (CSE:VGW) (the “Company” or “Valens”), a multi-licenced, vertically integrated provider of cannabis products, is pleased to announce it has arranged for a $5,000,000 private placement consisting of 3,571,429 shares at a price of $1.40 per share (the “Offering”).

Proceeds of the Offering will be used for additional growing

Valens GroWorks Receives Processing License

Valens GroWorks Receives Processing License

Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licensed, vertically integrated provider of cannabis products, is pleased to announce it has been granted Health Canada approval for the manufacture and packaging of cannabis oil products for sale to Licensed Producers, Licensed Dealers and approved Clinical Trials.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
The Case for Investing in Biotech

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/investing-in-biotech/